Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Metoclopramide in Acute Gastroenteritis
NCT05876585Phase 3Not yet recruiting
- Sponsor
- Genuine Research Center
- Start
- Jun 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of ondansetron in acute gastroenteritis (2 arms), sponsored by Genuine Research Center. Primary endpoints: Proportion of patients experiencing complete control of nausea and vomiting at 6 hours, Proportions of patients who experienced nausea, vomiting, or retching at 6 hours and 4 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
acute gastroenteritis
Beyond the preview
Go deeper on NCT05876585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05876585.